Weight-loss drug cuts heart attack risk regardless of kilograms shed, study finds
Semaglutide study suggests such drugs could have wider benefits, though researchers find shrinking waistlines linked to better heart outcomes The weight-loss drug semaglutide cuts the risk of heart attack or stroke regardless of how many kilograms people lose, the largest study of its kind has (…)
Site référencé:
The Guardian (Middle East)
4121.jpg?width=140&quality=85&auto=format&fit=max&s=5a7053f34e59ba13254453e1d8e8dc9f, 4121.jpg?width=460&quality=85&auto=format&fit=max&s=4edf2cd7a858c4692127db948688dac7, 4121.jpg?width=700&quality=85&auto=format&fit=max&s=2d77e43d31ede1e3448b6256e6f87a54
The Guardian (Middle East)
Barclays can afford Tricolor loss but risks remain in the private credit market
22/10/2025
Aprons are in fashion – but will they make you look like a trad wife ?
22/10/2025
The housing crisis needs better solutions than this | Letters
22/10/2025
Changing UK settlement rule to 10 years is unfair | Letter
22/10/2025
Fair Work Agency requires proper resources | Letter
22/10/2025
‘Non-crime hate’ or differing opinions ? | Brief letters
22/10/2025